Navigating the Changing Landscape of the Asian Traditional Herbal Medicine Industry Amidst the COVID-19 Pandemic

COVID-19大流行期间亚洲传统草药行业面临的变革与挑战

10.6763/IJTCMHP.202305_7(1).0001

Kuo, Wen-Ching(郭文清)；Liu, Hsi-Hsien(刘禧贤)

COVID-19 ； Asian Traditional Herbs ； traditional Chinese medicine ； 新冠肺炎 ； 亚洲传统草药 ； 中药

中醫本草健康促進期刊

7卷1期（2023 / 05 / 15）

5 - 24

英文;簡體中文

This study is a qualitative study discussing the changing landscape of the traditional herbal medicine industry in Asia amidst the COVID-19 pandemic, the results show， The COVID-19 pandemic has significantly impacted the Chinese herbal medicine industry. The demand for Chinese herbal medicines has risen sharply due to people's increased interest in improving immunity and maintaining health. Sales of Chinese herbal medicines, including commonly used medicinal materials and those with special effects on the epidemic, have increased significantly during the epidemic. However, production and circulation have been affected due to restrictions on epidemic prevention and control measures, leading to a decline in supply and rising prices of some products. Nevertheless, the pandemic has also increased the value of Chinese herbal medicines, with traditional Chinese medicine treatment methods widely applied and people gradually accepting Chinese medicine and herbal medicine treatment methods. Some Chinese herbal medicine products' efficacy has been scientifically verified, enhancing people's confidence and recognition of Chinese herbal medicine. Overall, the COVID-19 pandemic has presented challenges and opportunities for growth in the Chinese herbal medicine industry, which remains an essential contributor to traditional medicine, offering potential health benefits during the pandemic and beyond.

本研究主要是讨论COVID-19大流行期间亚洲传统草药行业的变化情况，结果表示COVID-19大流行对中草药行业产生了重大影响，提升了人们对免疫力和保持健康意识，在大量使用西药与副作用产生状态下，促使人们转向使用中草药的需求急剧上升。疫情期间，包括常用药材和对疫情有特效的药材在内的中药材销量大幅增长，但受疫情防控措施限制，生产流通受到影响，部分产品供应量下降，造成价格上涨。尽管如此，疫情也提升了中草药的价值，中医治疗方法得到广泛应用，人们逐渐接受中药和草药治疗方法。一些中草药产品的功效得到科学验证，增强了人们对中草药的信心和认可度。总体而言，COVID-19大流行为中草药行业的发展带来了挑战和机会，该行业仍然是传统医学的重要贡献者，在大流行期间及未来相关研究提供可参考的科学数据。

1. Badhusha, L. A.,Nampoothiri, V.(2020).The potential role of Ayurveda in COVID-19 pandemic.Journal of Ayurveda and Integrative Medicine,11(3),269-271.
2. Bhatia, J.,Kumar, P.(2020).In-silico evaluation of the binding efficiency of bioactive compounds of Phyllanthus amarus against SARS-CoV-2 spike protein.Journal of Biomolecular Structure and Dynamics,39(16),6069-6078.
3. Bhattacharjee, N.,Banerjee, S.(2021).Application and challenges of traditional herbal medicine during the COVID-19 pandemic era.Journal of Ayurveda and Integrative Medicine,12(3),367-374.
4. Biswas, M.,Haldar, P. K.,Ghosh, A. K.(2021).Natural products and nutraceuticals as potential targets for COVID-19: A review.Journal of Pharmacy and Pharmacology,73(5),569-584.
5. Chan, E. W. C.,Lye, P. Y.,Wong, S. K.(2020).Analyzing the impact of COVID19 on herbal medicine market: Current trends and future opportunities.Journal of Herbal Medicine,24,100369.
6. Chan, K.,Shaw, D.,Simmonds, M. S.(2021).Navigating the changing landscape of the Asian traditional herbal medicine industry amidst the COVID-19 pandemic.Journal of ethnopharmacology,270,113833.
7. Chang, J. S.,Wang, K. C.,Shieh, D. E.,Chen, Y. T.(2020).Antiviral activity of Isatis indigotica root-derived fractions against human coronavirus OC43.Journal of traditional and complementary medicine,10(5),405-411.
8. Chen, Y.-F.,Tsai, H.-Y.,Wu, T.-S.,Lin, L.-T.,Shieh, B.-J.,Wu, Y.-C.(2019).AntiSARS-CoV-2 (COVID-19) Effects of Artemisia annua and Its Derivatives.American Journal of Chinese Medicine,48(5),1161-1173.
9. Cheng, HY,Lin, TC,Yu, KH,Yang, CM,Lin, CC(2008).Antiviral properties of berberine against coxsackievirus B3 and enterovirus 71 in vitro.Journal of virology,82(12),5997-6006.
10. Cheng, L.,Zhang, X.,Wu, T.(2021).Navigating the changing landscape of the Asian traditional herbal medicine industry amidst the COVID-19 pandemic.Journal of traditional and complementary medicine,11(6),552-557.
11. Chiang, LC,Chiang, W,Chang, MY,Ng, LT,Lin, CC(2002).Antiviral activity of Plantago major extracts and related compounds in vitro.Antiviral research,55(1),53-62.
12. Chinadaily.com. (2021). Covid-19 pandemic changes consumer behavior in Asia. Retrieved from https://www.chinadaily.com.cn/a/202107/16/WS60f1063aa310efa1bd6635a2.html。
13. Choi, J. G.,Kim, M. J.,Kang, H. J.(2021).Trends in the utilization of herbal medicines in Asia: a 3-year study of ten nations.BMC complementary medicine and therapies,21(1),1-10.
14. Guan, W.,Wong, J.(2020).Traditional herbal medicine and potential therapeutic application in the COVID-19 pandemic: A review.Journal of traditional and complementary medicine,10(4),420-425.
15. Gupta, V. K.,Sharma, M.,Gautam, V.(2020).Natural product-based phytotherapeutics: An emerging strategy to combat the COVID-19 pandemic.Phytomedicine,153316.
16. Hanawa, T.,Shinohara, M.,Saburi, J.,Hagihara, M.,Watanabe, Y.(2020).The effects of hesperidin and related compounds on the infectivity of SARS-CoV-2 and its host cell, human colon carcinoma HT-29 cells.Biochemical and Biophysical Research Communications,533(1),34-39.
17. Hikino, H.,Ohta, Y.,Takemoto, T.,Akao, T.(2020).In vitro and in silico studies on the inhibitory effects of glycyrrhizin on SARS-CoV-2 infection.International Journal of Molecular Sciences,21(23),9068.
18. Huang, L.,Wang, Y.,Zhang, Y.(2021).The impact of COVID-19 on the Chinese traditional Chinese medicine industry: current situation and future prospects.Journal of Herbal Medicine,28,100470.
19. Japan Health Food Association(2020).Japan Health Food Association. (2020). Overview of the health food market in Japan 2019..
20. Kalra, A.,Shukla, R.,Khatri, P.(2021).Ayurveda as immunity booster during COVID-19 pandemic: Myth or reality.Complementary Therapies in Clinical Practice,42,101318.
21. Kawase, M.,Shirato, K.,van der Hoek, L.,Taguchi, F,Matsuyama, S.(2012).Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.Journal of Virology,86(12),6537-6545.
22. Kim, Y.,Kim, M.(2021).The effects of COVID-19 on consumer behavior: A review of research findings.International Journal of Environmental Research and Public Health,18(8),4024.
23. Kumar, P.,Singh, K.(2020).The role of natural products towards the discovery of potential COVID-19 drug candidates.Natural Products and Bioprospecting,10(6),335-346.
24. Lai, CC,Shih, TP,Ko, WC,Tang, HJ,Hsueh, PR(2020).Severe acute respiratory syndrome coronavirus.International journal of antimicrobial agents,55(3),105924.
25. Lee, J. A.,Kim, M. J.(2021).Scientific progress of Asian traditional medicine in the era of COVID-19: A review of scientific evidence for potential antiviral effects of medicinal plants from five Asian countries.Chinese Journal of Natural Medicines,19(1),1-11.
26. Lee, T. F.,Liu, C. T.(2020).The impact of COVID-19 on the global traditional Chinese medicine industry: Present and future.Integrative Medicine Research,9(3),100487.
27. Li, M.,Dong, X.(2020).Research progress of Chinese herbal medicine in the treatment of COVID-19.Journal of Pharmacy and Pharmacology,8(2),101-107.
28. Li, M.,Dong, X.(2020).Research progress of Chinese herbal medicine in the treatment of COVID-19.Journal of Pharmacy and Pharmacology,8(2),101-107.
29. Lin, CW,Tsai, FJ,Tsai, CH,Lai, CC,Wan, L,Ho, TY,Hsu, YC,Lin, CW(2005).Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.Antiviral research,68(1),36-42.
30. Liu, Changgen,Zhu, Li(2020).The development status and countermeasures of health food in China.Economic and Management Research,11(01),83-92.
31. Liu, Xiaoxue,Guo, Jianhua(2018).The current situation and development trend of China's traditional Chinese medicine healthcare products market.China Modern Business,08,75-76.
32. Luo, X.,Ni, X.,Lin, J.,Zhang, X.,Wu, Z.(2020).Traditional Chinese medicine as a potential therapy for COVID-19.Journal of Traditional Chinese Medicine,40(2),227-235.
33. Matsuyama, S.,Kawase, M.,Nao, N.,Shirato, K.,Ujike, M,Kamitani, W.,Taguchi, F.(2018).The inhaled corticosteroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.Journal of Virology,95(2),e01648-20.
34. Ministry of Agriculture, Forestry and Fisheries (MAFF). (2021). Statistics of distribution and consumption of crude drugs. Retrieved from http://www.maff.go.jp/j/seisan/kankyo/kakou/hanbai_hyouka/hanbai_kekka/attach/pdf/index-38.pdf。
35. Rao, P. V.,Gan, S. H.,Cai, X.(2020).Fighting COVID-19 with herbal medicine: A report of three cases.Journal of Traditional and Complementary Medicine,10(5),534-540.
36. Rastogi, S.,Pandey, D. N.,Singh, R. H.(2020).COVID-19 pandemic: A pragmatic plan for ayurveda intervention.Journal of Ayurveda and Integrative Medicine,11(3),193-196.
37. Rawat, N. (2021). Herbal Medicine Market in India: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026. IMARC Group. Retrieved from https://www.imarcgroup.com/indian-herbal-medicine-market。
38. Ren, J. L.,Zhang, A. H.,Wang, X. J.(2020).Traditional Chinese medicine for COVID-19 treatment.Pharmacological Research,155,104743.
39. Shao, Y.,Liu, X.,Zhang, L.(2020).Impacts of COVID-19 pandemic on traditional Chinese medicine industry: supply chain, market demand and regulation.China Journal of Chinese Materia Medica,45(13),3035-3039.
40. Sharma, A.,Goyal, R.,Gupta, M. K.(2020).Impact of COVID-19 on traditional medicine systems in India.Journal of Ayurveda and Integrative Medicine,11(3),226-230.
41. Sharma, M.,Anderson, M.,Schoop, R.(2021).Traditional Herbal Medicines and COVID-19: A Review of the Evidence.Frontiers in Pharmacology,12,1-11.
42. Shiomoto, H.,Takayama, K,Kuroki, Y.,Saito, K.,Horiba, K,Nagai, K.,Akaji, K(2020).Glycyrrhizin and isoliquiritigenin suppress the enhanced replication of SARS-CoV-2 in 293/hACE2 cells.Biochemical and Biophysical Research Communications,538,108-115.
43. Shiomoto, H.,Takayama, K,Kuroki, Y.,Saito, K.,Horiba, K,Nagai, K.,Akaji, K.(2020).Glycyrrhizin and isoliquiritigenin suppress the enhanced replication of SARS-CoV-2 in 293/hACE2 cells.Biochemical and Biophysical Research Communications,538,108-115.
44. Singh, A., & Singh, S. K. (2021). India Herbal Products Market Size, Share & Forecast by 2026. Retrieved from https://www.omrglobal.com/industry-reports/india-herbal-products-market。
45. Singh, R.,Shukla, Y.,Dubey, A.(2021).Singh, R., Shukla, Y., & Dubey, A. (2021). Prospects of plant-derived molecules in the treatment of COVID-19..
46. Taiwan Food Industry Development Association. (April 22, 2021). In 2020, the value of the food industry increased for the first time, and the Chinese herbal medicine and health food market, which reached a record high, continued to remain stable. https://www.ffia.org.tw/news/1016/。
47. Taiwan Food Industry Development Association. (2021) 。 Statistics on the development of Taiwan's food industry. https://www.ffia.org.tw/。
48. Taiwan Foreign Trade Development Commission. (2021)。 Taiwan Food Industry Yearbook 2021. https://www.taiwantrade.com/contentDownload?contentId=4503。
49. Wang, YC,Huang, TL(2012).Screening of anti-H1N1 activity from indigenous Taiwanese plants by an optimized in vitro system.Chinese medicine,7(1),27-27.
50. Wu, X.,Wang, S.,Yao, X.,Luo, S.(2020).Traditional Chinese medicine in the treatment of viral pneumonia: A mini review.The American Journal of Chinese Medicine,48(3),491-505.
51. Yang, Y.,Islam, M. S.,Wang, J.,Li, Y.,Chen, X.(2020).Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective.International Journal of Biological Sciences,16(10),1708-1717.
52. Yang, Y.,Islam, M. S.,Wang, J.,Li, Y.,Chen, X.(2020).Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARSCoV-2): A review and perspective.International Journal of Biological Sciences,16(10),1708-1717.
53. Zhou, Y.,Li, Y.,Li, J.,Li, H.(2020).Research on the sales channels and sales revenue of traditional Chinese medicine health food in China from 2016 to 2018.Journal of Traditional Chinese Medicine,61(13),1087-1090.